MAGCELL® MICROCIRC Leads to Volume Reduction in Benign Prostate Hyperplasia BPH - New Study
Therapeutic Use of Pulsed Electromagnetic Field Therapy Reduces Prostate Volume and Lower Urinary Tract Symptoms in Benign Prostatic Hyperplasia. Andrology. 2020 Feb 23. Authors: Tenuta M, Tarsitano MG, Mazzotta P, Lucchini L, Sesti F, Fattorini G, Pozza C, Olivieri V, Naro F, Gianfrilli D, Lenzi A, Isidori AM, Pofi R.
- (1888PressRelease) March 21, 2020 - Nottingham, Nottinghamshire, United Kingdom., March 20, 2020 -- The treatment (2 x 5 min. daily) resulted in a significant volume reduction of the prostate after only 28 days of therapy (V1) compared to the start of treatment (V0). That the therapy effect is sustainable is shown by the fact that even after 4 months (V2) there was a significantly reduced prostate volume compared to the start of treatment (V0). The survey on quality of life (IPSS questionnaire: urination/quality of life) also showed significantly better results at both points in time (V1 and V2) than V0. Overall, there was a rapid improvement in symptoms without changes in gonadal hormones or sexual function, with high compliance and without side effects.
Best results were achieved in moderate to severe symptoms (LUTS) and patients without metabolic syndrome (MetS).
doi: 10.1111/andr.12775. [Epub ahead of print] PubMed PMID: 32090492
MAGCELL MICROCIRC SPECIAL FEATURES
- Electrode-free electrotherapy for therapists and patients
- Pulsating electromagnetic fields (PEMF)
- Field strength more than 1000 gauss
- Effective treatment concept due to repeatable short-treatment periods
- Through-textile treatment (even through shoes)
PRICE: £485.00 including vat and delivery in the UK and Ireland.
Please email info ( @ ) physioequipment dot co dot uk for an order form which includes contraindications dot
Read the diary of a gentleman using the Magcell Microcirc for BPH
Read about the success of Magcell Vetri in the canine model for BPH in The Prostate- Effect of pulsed electromagnetic field therapy on prostate volume and vascularity in the treatment of benign prostatic hyperplasia: A pilot study in a canine model
About PhysioPod UK Limited:
PhysioPod UK Limited was established in 2006 and they are the UK & Ireland Distributor for the range of medical products from PHYSIOMED in Germany. PhysioPod UK Limited and Physio Equipment UK are leading the way in rehabilitation, sports and aesthetic medicine in the UK and Ireland with the latest physiotherapy products and innovative technical solutions. Offering an excellent price-performance ratio as well as new therapeutic approaches. In 2012, they became Approve NHS and AACP Suppliers.
Contact:
Mary Fickling
PhysioPod UK Limited
Sherbrook Road
Daybrook, Nottingham NG5 6AS
01159167685
info ( @ ) physiopod dot co dot uk
http://www.physiopod.co.uk
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam